PINELOPI ASSIMIS PAEDIATRICS
23 E WESTBOURNE TERRACE, LONDON  W2 3UN- Active
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Company No. 15479661
- Last Updated: 01 Mar 2024
Company Profile
PINELOPI ASSIMIS PAEDIATRICS was incorporated on Saturday, February 10, 2024 as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) with registered address in LONDON. PINELOPI ASSIMIS PAEDIATRICS has the status: Active and it's listed in the following category: Hospital activities. This PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) has been operating for 1 year and 13 days.
Name | PINELOPI ASSIMIS PAEDIATRICS |
---|---|
Company number | 15479661 |
Company type | PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) |
Incorporation date | 10 Feb 2024 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
23 E WESTBOURNE TERRACE LONDON W2 3UN |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mrs Pinelopi Assimis Nationality: Greek |
Dates: Saturday, February 10, 2024 - present
voting rights 75 to 100 percent
right to appoint and remove directors
|
Mr Christos Mitropoulos Nationality: British |
Dates: Saturday, February 10, 2024 - present
significant influence or control
|
Accounts and Confirmation
Type of accounts | NO ACCOUNTS FILED |
---|---|
End of financial Year | 29 February |
Next annual accounts due | 10 November 2025, (259 days left) |
Latest accounts | Not available |
Next confirmation statement due | 10 March 2025 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against PINELOPI ASSIMIS PAEDIATRICS.
Previous Names
Name | Change Date |
---|---|
PINELOPI ASSIMIS PAEDIATRICS | 10 Feb 2024 |